All Regulation articles – Page 22
-
BusinessChemical industry roundup 2017
Economic and political pressure is encouraging industry to become more specialised as certain sectors consolidate
-
BusinessEU extends glyphosate licence by 5 years
Extending herbicide’s approval until December 2022 has pleased neither industry nor environmental campaigners
-
NewsMisconduct scandal hits UK forensics lab
Thousands of criminal cases may have to be revisited due to botched drug tests
-
BusinessEuropean drug regulator heads to Amsterdam
Brexit drives EMA to relocate, taking hundreds of jobs and significant expertise away from UK
-
BusinessChina clamps down on polluting factories
Thousands of factories face closure or sanctions as authorities exercise new powers to curb air and water pollution
-
BusinessExxonMobil agrees to install pollution controls
Settlement with US government compels firm to improve emissions control and monitoring at eight chemical plants
-
OpinionAre trade sanctions fair?
How much should markets be protected from cheaper imports? When does healthy competition become ‘dumping’?
-
NewsToxic tattoo inks face EU chemicals agency controls
Proposal to regulate 4000 substances used in permanent make-up and tattoo inks
-
NewsNew guidelines to standardise toxicity testing for nanomaterials
OECD hopes methods will ensure companies are singing from same song sheet on nanosafety
-
BusinessDrug formula change infuriates French thyroid patients
Poor communication of changes to Merck KGaA’s levothyroxine has led to complaints of side effects
-
NewsUproar over EPA’s plan to ban its grantees from science committees
EPA chief says members of its scientific advisory panels get ‘millions of dollars’ in grants from the agency, which poses conflicts of interest
-
BusinessEx-Chemours worker tried to steal trade secrets
Employee intended to sell confidential information about sodium cyanide to Chinese investors to set up competing plants
-
BusinessFederal court quashes Allergan eye drop patents
Ruling negates company’s deal with Mohawk tribe to avoid patent board review
-
BusinessBASF to buy Bayer seeds and herbicides
€5.9bn sale will help satisfy competition regulators’ worries over Bayer–Monsanto merger
-
BusinessCall for overhaul of EU rules on GMO clinical trial
Rules designed around genetically modified plants crops are holding back new cell and gene-based medicines
-
BusinessResidents sue Arkema over contamination
French chemical giant accused of releasing toxic chemicals from US plant in the wake of hurricane Harvey
-
NewsBan on the sale of acids to under-18s planned in UK
Home secretary announces measures to combat acid attacks
-
BusinessUS government urged to exercise drug patent rights
Campaign group says withdrawing Biogen’s license to government patents, or re-licensing them to other companies, could lower MS drug prices
-
BusinessUS state passes law blocking generic drug price-gouging
Despite industry opposition, Maryland will be able to fine companies for ‘excessive and unjustified’ price increases
-
BusinessAmgen partners to launch biosimilars in China
US biopharma and Chinese generics firm will co-develop medicines from Amgen’s pipeline focused on inflammation and oncology